StockData
NeuroPace Inc logo

NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)

Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%

NeuroPace operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

NeuroPace's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.24M. For fiscal 2025 it was -$11.01M. The highest annual figure on record is -$11.01M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.01M–
FY2024Dec 31, 2024-$17.95M–
FY2023Dec 31, 2023-$19.70M–
FY2022Dec 31, 2022-$36.87M–
FY2021Dec 31, 2021-$24.58M–
FY2020Dec 31, 2020-$21.61M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.90M–
Q1 FY2026Mar 31, 2026-$5.90M–
Q4 FY2025Dec 31, 2025$506.00K–
Q3 FY2025Sep 30, 2025-$1.94M–
Q2 FY2025Jun 30, 2025-$2.09M–
Q1 FY2025Mar 31, 2025-$7.48M–
Q4 FY2024Dec 31, 2024-$4.80M–
Q3 FY2024Sep 30, 2024-$1.72M–
Q2 FY2024Jun 30, 2024-$3.90M–
Q1 FY2024Mar 31, 2024-$7.53M–
Q4 FY2023Dec 31, 2023-$3.34M–
Q3 FY2023Sep 30, 2023-$2.30M–
Q2 FY2023Jun 30, 2023-$4.36M–
Q1 FY2023Mar 31, 2023-$9.70M–
Q4 FY2022Dec 31, 2022-$7.84M–
Q3 FY2022Sep 30, 2022-$6.98M–
Q2 FY2022Jun 30, 2022-$10.66M–
Q1 FY2022Mar 31, 2022-$11.39M–
Q4 FY2021Dec 31, 2021-$8.20M–
Q3 FY2021Sep 30, 2021-$4.42M–
Q2 FY2021Jun 30, 2021-$6.01M–
Q1 FY2021Mar 31, 2021-$5.94M–
Q4 FY2020Dec 31, 2020-$6.42M–
Q3 FY2020Sep 30, 2020-$5.43M–
Q2 FY2020Jun 30, 2020-$3.21M–
Q1 FY2020Mar 31, 2020-$6.55M–

More NeuroPace figures

See a number that looks wrong?